About Dogwood Therapeutics Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://dwtx.com/
Frequently Asked Questions
What is the 52-week range for DWTX?
The 52-week high is $7.3 and the 52-week low is $1.28.
What is the P/E ratio for DWTX?
The P/E ratio data is currently unavailable.
What is the dividend yield for DWTX?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -35.91%.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.65.
Analyst Recommendation Trends
Wall Street analyst consensus for DWTX over the last few months:
Latest DWTX News
Dogwood Announces Completion of Enrollment in Ongoing Halneuron® Phase 2b Trial
- Enrollment of 239 Patients Meets Upper End of Planned Enrollment Target Range - - Topline Data Expected in November 2026 - ATLANTA, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a company that focuses on developing first-in-class, new non-opioid medicines to treat pain and neuropathy, today announced the completion of patient enrollment in its ongoing Halneuron® Phase 2b Chemotherapy Induced Neuropathic Pain (“CINP”) trial. The Compa
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) shares rose 25.3% to $2.08 during Friday's after-market session. The market value of their outstanding shares is at $1.1 million. Corbus Pharmaceuticals
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Immuron (NASDAQ:IMRN) stock increased by 64.9% to $1.83 during Friday's pre-market session. The company's market cap stands at $8.9 million. Akanda (NASDAQ:AKAN) shares increased by 27.52% to $4.68.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-06-16 | Whitley Richard James | +16,800 | - | - |
| 2026-06-16 | Thomas John C | +16,800 | - | - |
| 2026-03-05 | Duncan Gregory Scott | +330,000 | - | - |
| 2026-03-05 | Gendreau Roger Michael | +82,500 | - | - |
| 2026-03-05 | Grosswald Ralph | +82,500 | - | - |
| 2026-03-05 | Walsh Angela | +82,500 | - | - |
| 2025-12-04 | Duncan Gregory Scott | +460,000 | - | - |
| 2025-12-04 | Gendreau Roger Michael | +150,000 | - | - |
| 2025-12-04 | Grosswald Ralph | +150,000 | - | - |
| 2025-12-04 | Walsh Angela | +150,000 | - | - |
| 2025-11-21 | CK Life Sciences Intl (Holdings) Inc | -284 | - | - |
| 2025-11-21 | CK Life Sciences Intl (Holdings) Inc | -2,161 | - | - |
| 2025-11-21 | CK Life Sciences Intl (Holdings) Inc | +2,842,638 | - | - |
| 2025-11-21 | CK Life Sciences Intl (Holdings) Inc | +21,610,950 | - | - |